Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $21.21B as of Wednesday, August 5, 2026.
ENTERPRISE VALUE (EV)
$21.21B
Incyte Corporation
Market Cap
$24.28B
Enterprise Value (EV)
$21.21B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Incyte Corporation (INCY) | $24.28B | $21.21B |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | $24.42B |
| BioNTech SE (BNTX)vs › | $23.16B | $12.01B |
| Labcorp Holdings Inc. (LH)vs › | $25.74B | $32.24B |
| STERIS plc (STE)vs › | $22.68B | $24.34B |
| Quest Diagnostics Incorporated (DGX)vs › | $26.03B | $31.55B |
| Waters Corporation (WAT)vs › | $26.07B | $30.62B |
| Moderna, Inc. (MRNA)vs › | $22.32B | $22.12B |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | $20.94B |
| Viatris Inc. (VTRS)vs › | $20.55B | $33.09B |
Market Cap
$24.28B
Total Debt
$24.72M
Cash
$3.10B
Enterprise Value
$21.21B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
